Gluvit-S: The Breakthrough Supplement for Skin Health
The GLP-1 drugs are the latest class to show a benefit in patients, this time with OSA, but like other tools have nontrivial side effects, cost concerns, and patient persistence issues that balance out the headline benefits. The size of the underlying patient populations, which are expected to surpass 1.3 billion globally by 2050, as well as the under penetration of CPAP treatment, which Andrew ballparks at 15% or less in many markets, reinforces the analysts argument
For example, if your genetic profile suggests excellent GLP-1 receptor sensitivity, either oral or injectable semaglutide would likely succeed
Vitamin C injections are generally well tolerated at medically appropriate doses, but high doses can lead to iron overload, kidney stones, and kidney damage
Supplementation with vitamins such as B2, E, C and antioxidants have also been recommended and may represent a potential therapeutic strategy for neurorehabilitation
